• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    53.20 -0.19 (-0.36%)
    Streaming Delayed Price Updated: 10:10 AM EDT, Mar 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Moderna, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
    Via StockStory
    News headline image
    BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
    In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the... 
    Via MarketMinute
    Which S&P500 stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    3 Unprofitable Stocks That Concern Us
    Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding... 
    Via StockStory
    News headline image
    PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
    Via StockStory
    Topics Economy
    These S&P500 stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
    On March 6, 2026, Moderna, Inc. (NASDAQ: MRNA) remains the centerpiece of biotech conversations following a staggering 14% surge in its share price earlier this week. For a company that became a... 
    Via Finterra
    Topics Initial Public Offering Intellectual Property
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    What's going on in today's session: S&P500 movers ↗
    Via Chartmill
    News headline image
    Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
    In a landmark resolution that removes a multi-year shadow over the messenger RNA (mRNA) industry, Moderna, Inc. (NASDAQ:MRNA) has reached a comprehensive $2.25 billion global settlement with Genevant... 
    Via MarketMinute
    Topics Intellectual Property Lawsuit
    News headline image
    Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era
    Today’s Date: March 5, 2026 Introduction The narrative surrounding Moderna, Inc. (NASDAQ: MRNA) shifted dramatically this morning as the biotechnology pioneer’s shares surged 15.99%, reclaiming a level... 
    Via Finterra
    Topics Intellectual Property
    Tech Chips Lead Wall Street Rebound as Broadcom Crushes Estimates ↗
    Via Chartmill
    News headline image
    Why Moderna (MRNA) Stock Is Trading Up Today
    What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 17.4% in the afternoon session after the company settled a long-running patent di... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    News headline image
    Moderna-Arbutus-Genevant Patent Settlement: Wall Street Says Not Best-Case Scenario But Removes Overhang For MRNA Stock ↗
    The news is likely to come as a relief to many investors, Citi told investors in a research note. 
    Via Stocktwits
    Topics Intellectual Property
    Discover which S&P500 stocks are making waves on Wednesday. ↗
    Via Chartmill
    News headline image
    2 High-Flying Stocks With More Upside to Buy and Hold ↗
    It's not too late to get in on the action. 
    Via The Motley Fool
    Topics Artificial Intelligence Supply Chain
    Get insights into the top movers in the S&P500 index of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    MSTR, CRWD, MRNA, GTLB On Traders' Radar Today — Dow Futures Edge Higher As Investors Look Past Middle East Conflict ↗
    Following warnings from Iran over the closure of the Strait of Hormuz, President Donald Trump announced that the U.S. would extend risk insurance for maritime trade through the strait. 
    Via Stocktwits
    Topics ETFs Government Intellectual Property
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    MRNA Shares Rally After Hours On Inking Settlement Deal Over Vaccine Patent Row ↗
    The settlement resolves all enforcement actions involving Moderna’s use of Genevant’s and Arbutus’ LNP delivery technology in its COVID-19 vaccines. 
    Via Stocktwits
    Topics Intellectual Property
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    News headline image
    Moderna Stock (MRNA): Is It a Buy Now? 7 Questions After the Crash ↗
    Moderna stock has crashed 90% — but is the market mispricing what comes next? 7 key questions on MRNA's cancer vaccine, cash runway, and upside case. 
    Via InvestorPlace
    News headline image
    The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
    As of today, February 27, 2026, the biotech sector is witnessing a dramatic reappraisal of one of its most storied pandemic-era players. Novavax (NASDAQ: NVAX) has surged 17.4% following the release of... 
    Via Finterra
    Topics Economy
    News headline image
    Moderna's Ups and Downs: Here's What You Need to Know Before Investing. ↗
    The stock, after a few tough years, soared in the double-digits in January. 
    Via The Motley Fool
    News headline image
    3 Reasons to Avoid MRNA and 1 Stock to Buy Instead
    What a fantastic six months it’s been for Moderna. Shares of the company have skyrocketed 99.8%, hitting $50.65. This was partly due to its solid quarterly results, and the run-up might have investors... 
    Via StockStory
    News headline image
    Moderna Stock Is Trading Higher Today: What's Going On? ↗
    Moderna Inc (NASDAQ:MRNA) shares are trading higher on Monday. Piper Sandler boosted its price target on the stock to $69 from $63 while reiterating an Overweight rating. 
    Via Benzinga
    News headline image
    Here's Why I Wouldn't Touch Moderna With a 10‑Foot Pole Until Its Next Growth Engine Is Clear ↗
    Moderna made a fortune with COVID vaccines, but revenue has since declined. 
    Via The Motley Fool
    News headline image
    Billionaire Philippe Laffont Just Dumped CoreWeave and Opened a Position in a Stock That Soared Nearly 50% in January. ↗
    Laffont's new addition may represent an exciting recovery story. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Friday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.